Revisiting the natural history of chronic hepatitis B: Impact of new concepts on clinical management

Journal of Gastroenterology and Hepatology (Australia)

Volumn 22, Issue 7, 2007, Pages 973-976

  Yuen, Man Fung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Alanine aminotransferase level; Chronic hepatitis B; Hepatitis B e antigen seroconversion; Hepatitis B virus DNA; Natural history

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; INTERFERON; VIRUS DNA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASCITES; ASIA; BACTERIAL PERITONITIS; BRAIN DISEASE; CAUCASIAN; CHRONIC HEPATITIS; DISEASE COURSE; DISEASE EXACERBATION; ESOPHAGUS VARICES; HEPATITIS B; HEPATITIS B VIRUS; HIGH RISK POPULATION; HUMAN; IMMUNOLOGICAL TOLERANCE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER INJURY; NORMAL VALUE; ONSET AGE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; REVIEW; SEROCONVERSION; STOMACH VARICES; TREATMENT INDICATION; VIREMIA; VIRUS INHIBITION; VIRUS LOAD; VIRUS REPLICATION;

EID: 34347379602     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2007.04938.x     Document Type: Review

References (31)

1. Lai CL, Ratziu V, Yuen MF, Poynard T. Viral hepatitis B. Lancet 2003 362 : 2089 94.
2. Yuen MF, Lai CL. Natural history of chronic hepatitis B virus infection. J. Gastroenterol. Hepatol. 2000 15 (Suppl. E20 4.
3. Liaw YF, Sheen IS, Chen TJ et al. Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: a prospective study. Hepatology 1991 13 : 627 31.
4. McMahon BJ, Albers SR, Wainwright RB et al. Hepatitis B-related sequelae. Prospective study in 1400 hepatitis B surface antigen-positive Alaska Native carriers. Arch. Intern. Med. 1990 150 : 1051 4.
5. Hsu HY, Chang MH, Lee CY et al. Spontaneous loss of HBsAg in children with chronic hepatitis B virus infection. Hepatology 1992 15 : 382 6.
6. Alward WLM, McMahon BJ, Hall DB et al. The long-term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma. J. Infect. Dis. 1985 151 : 604 9.
7. Da Silva LC, De Assis Madruga CL, Carrilho FJ et al. Spontaneous hepatitis B surface antigen clearance in a long-term follow-up study of patients with chronic type B hepatitis: lack of correlation with hepatitis C and D virus infection. J. Gastroenterol. 1996 31 : 696 701.
8. Loriot MA, Marcellin P, Walker F et al. Persistence of hepatitis B virus DNA in serum and liver from patients with chronic hepatitis B after loss of HBsAg. J. Hepatol. 1997 27 : 251 8.
9. Fong TL, Di Bisceglie AM, Gerber MA et al. Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B. Hepatology 1993 18 : 1313 18.
10. Kuhns M, McNamara A, Mason A et al. Serum and liver hepatitis B virus DNA in chronic hepatitis B after sustained loss of surface antigen. Gastroenterology 1992 103 : 1649 56.
11. Yuen MF, Wong DKH, Sablon E et al. HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histologic and clinical aspects. Hepatology 2004 39 : 1694 701.
12. Wong DKH, Yuen MF, Yuan HJ et al. Quantitation of covalently closed circular hepatitis B virus DNA in chronic hepatitis B patients. Hepatology 2004 40 : 727 37.
13. Yuen MF, Sablon E, Hui CK et al. Prognostic factors in severe exacerbation of chronic hepatitis B. Clin. Infect. Dis. 2003 36 : 979 84.
14. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 1981 2 : 1129 33.
15. Manno M, Camma C, Schepis F et al. Natural history of chronic HBV carriers in northern Italy: morbidity and mortality after 30 years. Gastroenterology 2004 127 : 756 63.
16. Hoofnagle JH, Shafritz DA, Popper H. Chronic type B hepatitis and the 'healthy' HBsAg carrier state. Hepatology 1987 7 : 758 63.
17. Di Bisceglie AM, Waggoner JG, Hoofnagle JH. Hepatitis B virus deoxyribonucleic acid in liver of chronic carriers. Correlation with serum markers and changes associated with loss of hepatitis B e antigen after antiviral therapy. Gastroenterology 1987 93 : 1236 41.
18. Niederau C, Heintges T, Lange S et al. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B. N. Engl. J. Med. 1996 334 : 1422 7.
19. Yuen MF, Yuan HJ, Hui CK et al. A large population study of spontaneous HBeAg seroconversion and acute exacerbation of chronic hepatitis B infection: implications for antiviral therapy. Gut 2003 52 : 416 19.
20. Liaw YF, Tai DI, Chu CM, Chen TJ. The development of cirrhosis in patients with chronic type B hepatitis: a prospective study. Hepatology 1988 8 : 493 6.
21. Hsu YS, Chien RN, Yeh CT et al. Long-term outcome after spontaneous HbeAg seroconversion in patients with chronic hepatitis B. Hepatology 2002 35 : 1522 7.
22. Yuen MF, Yuan HJ, Wong DK et al. Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications. Gut 2005 54 : 1610 14.
23. Yang HI, Lu SN, Liaw YF et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N. Engl. J. Med. 2002 347 : 168 74.
24. Lok ASF, McMahon BJ. Chronic hepatitis B: update of recommendations. Hepatology 2004 39 : 857 61.
25. Yuan HJ, Yuen MF, Wong DKH, Sablon E, Lai CL. The relationship between HBV-DNA levels and cirrhosis-related complications in Chinese with chronic hepatitis B. J. Viral Hepat. 2005 12 : 373 9.
26. Chen CJ, Yang HI, Su J et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006 295 : 65 73.
27. Iloeje UH, Yang HI, Su J et al. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 2006 130 : 678 86.
28. Kim HC, Nam CM, Jee SH, Han KH, Oh DK, Suh I. Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study. BMJ 2004 328 : 983 7.
29. Nguyen MH, Trinh H, Garcia RT, Ahmad A, Keeffe EB. Signficant histologic disease in HBV-infected patients with normal to minimally elevated ALT levels at initial evaluation. Hepatology 2005 42 : 593A.
30. Lai M, Hyatt B, Afdahl N. Role of liver biopsy in patients with normal ALT and high HBV DNA. Hepatology 2005 42 : 720A.
31. Chu CM, Hung SJ, Lin J, Tai DI, Liaw YF. Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels. Am. J. Med. 2004 116 : 829 34.